CLENOST
Live / Registered — Registered (as of 02 Mar 2021)
What this means for you
Registered since 02 Mar 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88810001
- Registration number
- 6280345
- Mark type
- Stylized text
- Filed
- 25 Feb 2020
- Published for opposition
- 15 Dec 2020
- Registered
- 02 Mar 2021
- Attorney of record
- Christopher M. Hanes
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Owner
- Glaxo Group Limited, Brentford, Middlesex, GB
- Glaxo Group Limited, Brentford, Middlesex, GB
- Glaxo Group Limited, Brentford, Middlesex, GB
Prosecution history
- 02 Mar 2026 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 28 Oct 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 28 Oct 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 28 Oct 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 02 Mar 2021 — REGISTERED-PRINCIPAL REGISTER
- 15 Dec 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Dec 2020 — PUBLISHED FOR OPPOSITION
- 25 Nov 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 09 Nov 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 29 Oct 2020 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 29 Oct 2020 — LETTER OF SUSPENSION E-MAILED
- 29 Oct 2020 — SUSPENSION LETTER WRITTEN
- 10 Oct 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 09 Oct 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 09 Oct 2020 — TEAS RESPONSE TO OFFICE ACTION RECEIVED